일산화탄소 중독 환자에서 고유속 비강 캐뉼라 산소치료 효과에 대한 예비 연구
A Preliminary Study for Effect of High Flow Oxygen through Nasal Cannula Therapy in Carbon Monoxide Poisoning
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Acute carbon monoxide (CO) poisoning is one of the most common types of poisoning and a major health problem worldwide. Treatment options are limited to normobaric oxygen therapy, administered using a nonrebreather face mask or hyperbaric oxygen. Compared to conventional oxygen therapy, high-flow nasal cannula oxygen (HFNC) creates a positive pressure effect through high-flow rates. The purpose of this human pilot study is to determine the effects of HFNC on the rate of CO clearance from the blood, in patients with mild to moderate CO poisoning. Methods: CO-poisoned patients were administered 100% oxygen from HFNC (flow of 60 L/min). The fraction of COHb (fCOHb) was measured at 30-min intervals until it decreased to under 10%, and the half-life time of fCOHb (fCOHb t1/2) was subsequently determined. Results: At the time of ED arrival, a total of 10 patients had fCOHb levels ≥10%, with 4 patients ranging between 10% and 50%. The mean rate of fCOHb elimination patterns exhibits logarithmic growth curves that initially increase quickly with time (HFNC equation, Y=0.3388*X+11.67). The mean fCOHbt1/2 in the HFNC group was determined to be 48.5±12.4 minutes. Conclusion: In patients with mild to moderate CO poisoning, oxygen delivered via high flow nasal cannula is a safe and comfortable method to treat acute CO toxicity, and is effective in reducing the COHb half-life. Our results indicate HFNC to be a promising alternative method of delivering oxygen for CO toxicity. Validating the effectiveness of this method will require larger studies with clinical outcomes.
Abstract
Purpose: Acute carbon monoxide (CO) poisoning is one of the most common types of poisoning and a major health problem worldwide. Treatment options are limited to normobaric oxygen therapy, administered using a nonrebreather face mask or hyperbaric oxygen. Compared to conventional oxygen therapy, high-flow nasal cannula oxygen (HFNC) creates a positive pressure effect through high-flow rates. The purpose of this human pilot study is to determine the effects of HFNC on the rate of CO clearance from the blood, in patients with mild to moderate CO poisoning. Methods: CO-poisoned patients were administered 100% oxygen from HFNC (flow of 60 L/min). The fraction of COHb (fCOHb) was measured at 30-min intervals until it decreased to under 10%, and the half-life time of fCOHb (fCOHb t1/2) was subsequently determined. Results: At the time of ED arrival, a total of 10 patients had fCOHb levels ≥10%, with 4 patients ranging between 10% and 50%. The mean rate of fCOHb elimination patterns exhibits logarithmic growth curves that initially increase quickly with time (HFNC equation, Y=0.3388*X+11.67). The mean fCOHbt1/2 in the HFNC group was determined to be 48.5±12.4 minutes. Conclusion: In patients with mild to moderate CO poisoning, oxygen delivered via high flow nasal cannula is a safe and comfortable method to treat acute CO toxicity, and is effective in reducing the COHb half-life. Our results indicate HFNC to be a promising alternative method of delivering oxygen for CO toxicity. Validating the effectiveness of this method will require larger studies with clinical outcomes.
참고문헌 (19)
- Rose JJ, "Carbon Monoxide Poisoning:Pathogenesis, Management, and Future Directions of Therapy", Am J Respir Crit Care Med, 195, pp.596~606 (2017)
- Broome JR, "Hyperbaric oxygen for carbon monoxide poisoning", Lancet, 2, pp.1529~ (1989)
- Garg J, "Cardiovascular Abnormalities in Carbon Monoxide Poisoning", Am J Ther, 25, pp.e339~e348 (2018)
- Lin MS, "Myocardial injury was associated with neurological sequelae of acute carbon monoxide poisoning in Taiwan", J Chin Med Assoc, 81, pp.682~690 (2018)
- Satran D, "Cardiovascular manifestations of moderate to severe carbon monoxide poisoning", J Am Coll Cardiol, 45, pp.1513~1516 (2005)
- Oh S, "Acute carbon monoxide poisoning and delayed neurological sequelae : a potential neuroprotection bundle therapy", Neural Regen Res, 10, pp.36~38 (2015)
- Peters SG, "High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress", Respir Care, 58, pp.597~600 (2013)
- Carratala Perales JM, "High-Flow therapy via nasal cannula in acute heart failure", Rev Esp Cardiol, 64, pp.723~725 (2011)
- Ciuffini F, "Therapy with high-flow nasal prongs in preterm infants", Pediatr Med Chir, 35, pp.118~124 (2013)
- Marjanovic N, "Reply to Understanding the benefits of early high-flow nasal cannula for adults with acute hypoxemic respiratory failure in the ED", Am J Emerg Med, 37, pp.159~164 (2019)
- Weaver LK, "Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure", Chest, 117, pp.801~808 (2000)
- Kao LW, "Carbon monoxide poisoning", Emerg Med Clin North Am, 22, pp.985~1018 (2004)
- Burney RE, "Mass carbon monoxide poisoning : clinical effects and results of treatment in 184victims", Ann Emerg Med, 11, pp.394~399 (1982)
- Jay GD, "Portable hyperbaric oxygen therapy in the emergency department with the modified Gamow bag", Ann Emerg Med, 26, pp.707~711 (1995)
- Li CK, "A retrospective study on carboxyhaemoglobin half-life in acute carbon monoxide poisoning in patients treated with normobaric high flow oxygen levels", Hong Kong Journal of emergency medicine, 13, pp.205~211 (2006)
- Hampson NB, "Hyperbaric treatment of patients with carbon monoxide poisoning in the United States", Undersea Hyperb Med, 32, pp.21~26 (2005)
- 김은진, "Effectiveness and Safety of High-Flow Nasal Cannula Oxygen Delivery during Bronchoalveolar Lavage in Acute Respiratory Failure Patients", Tuberculosis and Respiratory Diseases, 81(4), pp.319~329 (2018), 대한결핵및호흡기학회
- Sharma S, "High Flow Nasal Cannula" (2019), Treasure Island
- Sotello D, "High-flow nasal cannula oxygen in adult patients : a narrative review", Am J Med Sci, 349, pp.179~185 (2015)